Table 4.

Association between the CTI and CVD mortality according to age

	Died/participants	Model 1	Model 2	Model 3
Age < 60
CVD mortality	48/5694
Q1	5/1690	1 (referent)	1 (referent)	1 (referent)
Q2	9/1392	1.58 (0.52–4.84)	1.78 (0.59–5.35)	2.35 (0.77–3.81)
Q3	16/12977	3.06 (1.02–9.13)*	3.64 (1.33–9.96)*	2.64 (1.69–4.56)**
Q4	18/1315	3.12 (0.96–10.11)	4.77 (1.75–12.97)**	3.49 (2.37–5.51)**
All-cause mortality	201/5694
Q1	38/1690	1 (referent)	1 (referent)	1 (referent)
Q2	53/1392	1.31 (0.85–2.03)	1.38 (0.91–2.10)	1.81 (1.19–2.80)**
Q3	43/1297	1.21 (0.74–1.96)	1.28 (0.83–1.99)	1.66 (1.10–2.60)*
Q4	67/1315	1.62 (0.97–2.70)	2.36 (1.58–3.53)**	3.31 (2.23–4.92)**
Total-CVD	245/5694
Q1	41/1690	1 (referent)	1 (referent)	1 (referent)
Q2	49/1392	1.03 (0.65–1.61)	1.17 (0.77–1.80)	1.49 (0.96–2.27)
Q3	53/1297	0.99 (0.62–1.60)	1.34 (0.88–2.04)	1.72 (1.14–2.61)*
Q4	102/1315	1.40 (0.87–2.25)	2.34 (1.60–3.42)	3.39 (2.34–4.93)**
Age >  = 60	2985
CVD mortality	312/2985
Q1	58/480	1 (referent)	1 (referent)	1 (referent)
Q2	82/778	0.92 (0.66–1.29)	0.97 (0.70–1.36)	0.94 (0.69–1.32)
Q3	92/873	1.01 (0.73–1.40)	1.11 (0.80–1.55)	1.13 (0.76–1.59)
Q4	80/954	1.17 (0.83–1.64)	1.47 (1.05–2.07)*	1.32 (0.85–1.99)
All-cause mortality	951/2985
Q1	167/480	1 (referent)	1 (referent)	1 (referent)
Q2	260/778	1.01 (0.83–1.23)	1.06 (0.87–1.28)	1.08 (0.89–1.35)
Q3	292/873	1.11 (0.92–1.34)	1.20 (0.99–1.45)	1.27 (1.06–1.55)*
Q4	232/854	1.17 (0.95–1.42)	1.41 (1.16–1.73)**	1.46 (1.15–1.82)**
Total-CVD	727/2985
Q1	99/480	1 (referent)	1 (referent)	1 (referent)
Q2	181/778	1.02 (0.75–1.38)	1.18 (0.89–1.57)	1.16 (0.85–1.57)
Q3	194/873	0.85 (0.63–1.16)	1.11 (0.84–1.47)	1.12 (0.86–1.47)
Q4	253/854	1.03 (0.74–1.42)	1.79 (1.37–2.35)**	1.60 (1.24–2.12)**

Model 1 did not adjust for any variables. Model 2 adjusted for sex and age. Model 3 adjusted for age, sex, education, race, smoking, alcohol use, self-reported diabetes, self-reported hypertension, systolic blood pressure (SBP), BMI, HDL, LDL, and HbA1c% levels

*P < 0.05, **P < 0.01